Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.25%
SPX
0.00%
IXIC
+0.31%
FTSE
+0.30%
N225
+1.65%
AXJO
-0.10%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
pdsb
PDS Biotechnology
PDSB
-0.08 (-5.00%)
1.52
USD
At close at Jun 25, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
68.55M
Dividend Yield
0.00%
P/E Ratio
-1.93
EPS
-1.03
Revenue
-
Avg. Volume
189.10K

About

What does PDSB do?
PDS Biotechnology, based in Princeton, New Jersey, develops clinical-stage immunotherapies for various cancers, including its lead product PDS0101, which targets HPV16. The company went public on October 1, 2015, and has 25 employees.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New Jersey, USA
Website
http://www.pdsbiotech.com
Join our newsletter to keep up to date with us!

Recently from Cashu

publisher logo
Cashu

PDS Biotechnology: TruGolf Launches Innovative Flagship Location to Transform Retail Entertainment

2 days ago
publisher logo
Cashu

PDS Biotechnology: Four Seasons Yachts Unveils Innovative Luxury Vessel for 2026 Launch

25 days ago
publisher logo
Cashu

PDS Biotechnology: Four Seasons Yachts Redefines Luxury with Innovative Vessel Launch

27 days ago